adenine has been researched along with cyclin d1 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, S; Han, Z; Obaya, AJ; Ramos-Desimone, N; Sedivy, JM; Wyche, JH | 1 |
| Ajani, JA; Chao, CK; Correa, A; Ensor, J; Hittelman, WN; Izzo, JG; Luthra, R; Pan, J; Swisher, SG; Wu, TT; Wu, X | 1 |
| Cho, SC; Ha, MK; Jang, IS; Park, SC; Rhim, JH; Song, KY; Yeo, EJ | 1 |
| Alinari, L; Baiocchi, RA; Christian, B | 1 |
| Chang, J; Cheng, L; Ji, D; Li, J; Liu, R; Liu, X; Sun, Z; Wang, C; Wang, S; Wang, X; Zhang, X; Zhang, Z; Zheng, B; Zheng, R | 1 |
| Hagiwara, K; Iida, H; Kunishima, S; Miyata, Y; Nagai, H; Naoe, T | 1 |
| Amin, HM; Chen, L; Chen, RW; Das, M; Marcucci, G; Mohanty, A; Ngo, VN; Pham, LV; Pillai, R; Rosen, ST; Sandoval, N; Wang, M; Weisenburger, DD | 1 |
| Bonaldi, L; Branca, A; Gurrieri, C; Manni, S; Martines, A; Piazza, F; Pizzi, M; Riva, M; Scapinello, G; Semenzato, G; Trentin, L; Visentin, A | 1 |
8 other study(ies) available for adenine and cyclin d1
| Article | Year |
|---|---|
c-Myc is necessary for DNA damage-induced apoptosis in the G(2) phase of the cell cycle.
Topics: Adenine; Animals; Apoptosis; CDC2-CDC28 Kinases; Cell Line; Cisplatin; Cross-Linking Reagents; Cyclin A; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Etoposide; Flow Cytometry; G1 Phase; G2 Phase; Immunoblotting; Kinetics; Mutagenesis, Site-Directed; Nucleic Acid Synthesis Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-myc; Rats; Recombination, Genetic; Time Factors; Transgenes | 2001 |
Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Topics: Adenine; Adenocarcinoma; Adult; Aged; Biomarkers, Tumor; Biopsy, Needle; Cohort Studies; Cyclin D1; Disease Progression; Esophageal Neoplasms; Esophagectomy; Esophagoscopy; Female; Gene Expression Regulation, Neoplastic; Genomic Instability; Guanine; Humans; Immunohistochemistry; Male; Middle Aged; Polymorphism, Genetic; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sensitivity and Specificity; Survival Analysis | 2007 |
Lysophosphatidic acid and adenylyl cyclase inhibitor increase proliferation of senescent human diploid fibroblasts by inhibiting adenosine monophosphate-activated protein kinase.
Topics: Adenine; Adenylyl Cyclase Inhibitors; AMP-Activated Protein Kinases; Cell Proliferation; Cells, Cultured; Cellular Senescence; Cyclic AMP-Dependent Protein Kinases; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Diploidy; Enzyme Inhibitors; Fibroblasts; Humans; Lysophospholipids; Models, Biological; Multienzyme Complexes; Phosphorylation; Protein Serine-Threonine Kinases; S Phase; Signal Transduction | 2008 |
Novel targeted therapies for mantle cell lymphoma.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antigens, CD20; Antigens, Differentiation, B-Lymphocyte; B-Lymphocytes; Cell Cycle; Clinical Trials as Topic; Cyclin D1; DNA Repair; Female; Histocompatibility Antigens Class II; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Molecular Targeted Therapy; NF-kappa B; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-akt; Purines; Pyrazoles; Pyrimidines; Quinazolinones; TOR Serine-Threonine Kinases; Translocation, Genetic | 2012 |
The combination of RAD001 and MK-2206 exerts synergistic cytotoxic effects against PTEN mutant gastric cancer cells: involvement of MAPK-dependent autophagic, but not apoptotic cell death pathway.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Butadienes; Cell Line, Tumor; Chloroquine; Cyclin D1; Drug Synergism; Everolimus; Flavonoids; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 3-Ring; Humans; Membrane Proteins; Microtubule-Associated Proteins; Mitogen-Activated Protein Kinases; Nitriles; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2014 |
The synergistic effect of BCR signaling inhibitors combined with an HDAC inhibitor on cell death in a mantle cell lymphoma cell line.
Topics: Adenine; Apoptosis; Caspases; Cell Line, Tumor; Cyclin D1; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lymphoma, Mantle-Cell; NF-kappa B; Oxazines; Piperidines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Receptors, Antigen, B-Cell; Vorinostat | 2015 |
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
Topics: Adenine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclin D1; Drug Resistance, Neoplasm; Humans; Lymphoma, Mantle-Cell; Mutation; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Protein Stability; Protein Transport; Proteolysis; Pyrazoles; Pyrimidines; Ubiquitination | 2016 |
A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib.
Topics: Abnormal Karyotype; Adenine; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Biomarkers, Tumor; Bortezomib; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 8; Cyclin D1; Cytarabine; Drug Resistance, Neoplasm; Fatal Outcome; Gene Duplication; Genes, myc; Humans; Lymphoma, Mantle-Cell; Male; Oncogene Proteins, Fusion; Piperidines; Pyrazoles; Pyrimidines; Recurrence; Rituximab; Translocation, Genetic | 2020 |